A cure rate survival model under a hybrid latent activation scheme
暂无分享,去创建一个
Narayanaswamy Balakrishnan | Francisco Louzada | Josemar Rodrigues | Patrick Borges | N. Balakrishnan | F. Louzada | Patrick Borges | J. Rodrigues
[1] R. Kay. The Analysis of Survival Data , 2012 .
[2] Narayanaswamy Balakrishnan,et al. Destructive weighted Poisson cure rate models , 2011, Lifetime data analysis.
[3] V. Cancho,et al. A note on a unified approach for cure rate models , 2010 .
[4] Narayanaswamy Balakrishnan,et al. COM–Poisson cure rate survival models and an application to a cutaneous melanoma data , 2009 .
[5] Josemar Rodrigues,et al. On the unification of long-term survival models , 2009 .
[6] R. Écochard,et al. Promotion Time Models with Time‐Changing Exposure and Heterogeneity: Application to Infectious Diseases , 2008, Biometrical journal. Biometrische Zeitschrift.
[7] Narayanaswamy Balakrishnan,et al. Connections of the Poisson weight function to overdispersion and underdispersion , 2008 .
[8] Bradley P Carlin,et al. Flexible Cure Rate Modeling Under Latent Activation Schemes , 2007, Journal of the American Statistical Association.
[9] Joseph G. Ibrahim,et al. Cure rate models: A unified approach , 2005 .
[10] Marta Pérez-Casany,et al. Overdispersed and underdispersed Poisson generalizations , 2005 .
[11] R. Rigby,et al. Generalized additive models for location, scale and shape , 2005 .
[12] Joseph G Ibrahim,et al. A General Class of Bayesian Survival Models with Zero and Nonzero Cure Fractions , 2005, Biometrics.
[13] Sudhir Paul,et al. Bias-corrected maximum likelihood estimator of the negative binomial dispersion parameter. , 2005, Biometrics.
[14] T. Minka,et al. A useful distribution for fitting discrete data: revival of the Conway–Maxwell–Poisson distribution , 2005 .
[15] Joseph G. Ibrahim,et al. Bayesian Survival Analysis , 2004 .
[16] Bradley P Carlin,et al. Parametric Spatial Cure Rate Models for Interval‐Censored Time‐to‐Relapse Data , 2004, Biometrics.
[17] J. Ibrahim,et al. Bayesian Inference for Multivariate Survival Data with a Cure Fraction , 2002 .
[18] Chin-Shang Li,et al. Identifiability of cure models , 2001 .
[19] Ana Maria Barral,et al. Immunological Studies in Malignant Melanoma : Importance of TNF and the Thioredoxin System , 2001 .
[20] Jim E. Griffin,et al. A Bayesian Partition Model for Customer Attrition , 2001 .
[21] V. Sondak,et al. High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] J. P. Sy,et al. Estimation in a Cox Proportional Hazards Cure Model , 2000, Biometrics.
[23] F Louzada-Neto,et al. Polyhazard Models for Lifetime Data , 1999, Biometrics.
[24] Joseph G. Ibrahim,et al. A New Bayesian Model For Survival Data With a Surviving Fraction , 1999 .
[25] R. Gunst. Applied Regression Analysis , 1999, Technometrics.
[26] Marta Pérez-Casany,et al. Weighted Poisson Distributions for Overdispersion and Underdispersion Situations , 1998 .
[27] N. Draper,et al. Applied Regression Analysis: Draper/Applied Regression Analysis , 1998 .
[28] A D Tsodikov,et al. A distribution of tumor size at detection: an application to breast cancer data. , 1997, Biometrics.
[29] A Stochastic Model of Carcinogenesis and Tumor Size at Detection , 1997, Advances in Applied Probability.
[30] Peter K. Dunn,et al. Randomized Quantile Residuals , 1996 .
[31] A Y Yakovlev,et al. A distribution of tumor size at detection and its limiting form. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[32] A. Yakovlev,et al. Stochastic Models of Tumor Latency and Their Biostatistical Applications , 1996 .
[33] A. Yakovlev,et al. A diversity of responses displayed by a stochastic model of radiation carcinogenesis allowing for cell death. , 1996, Mathematical biosciences.
[34] W. D. Ray. 4. Modelling Survival Data in Medical Research , 1995 .
[35] D. Collett. Modelling Survival Data in Medical Research , 1994 .
[36] A D Tsodikov,et al. A stochastic model of hormesis. , 1993, Mathematical biosciences.
[37] Pranab Kumar Sen,et al. Large Sample Methods in Statistics: An Introduction with Applications , 1993 .
[38] S T Rachev,et al. A stochastic model of radiation carcinogenesis: latent time distributions and their properties. , 1993, Mathematical biosciences.
[39] J J Shuster,et al. Parametric versus non-parametric methods for estimating cure rates based on censored survival data. , 1992, Statistics in medicine.
[40] A. Kopp-Schneider,et al. The application of a multistage model that incorporates DNA damage and repair to the analysis of initiation/promotion experiments. , 1991, Mathematical biosciences.
[41] W. Piegorsch. Maximum likelihood estimation for the negative binomial dispersion parameter. , 1990, Biometrics.
[42] N. Gordon,et al. Application of the theory of finite mixtures for the estimation of 'cure' rates of treated cancer patients. , 1990, Statistics in medicine.
[43] Vernon T. Farewell,et al. Mixture models in survival analysis: Are they worth the risk? , 1986 .
[44] D. A. Preece,et al. The negative binomial distribution , 1985 .
[45] A I Goldman,et al. Survivorship analysis when cure is a possibility: a Monte Carlo study. , 1984, Statistics in medicine.
[46] V. Farewell,et al. The use of mixture models for the analysis of survival data with long-term survivors. , 1982, Biometrics.
[47] C. R. Rao,et al. On discrete distributions arising out of methods of ascertainment , 1965 .
[48] Joseph Berkson,et al. Survival Curve for Cancer Patients Following Treatment , 1952 .
[49] Feller William,et al. An Introduction To Probability Theory And Its Applications , 1950 .
[50] R. Fisher. THE EFFECT OF METHODS OF ASCERTAINMENT UPON THE ESTIMATION OF FREQUENCIES , 1934 .